326030 — SK Biopharmaceuticals Co Cashflow Statement
0.000.00%
- KR₩7tn
- KR₩7tn
- KR₩355bn
Annual cashflow statement for SK Biopharmaceuticals Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -71,519 | -247,414 | 64,846 | -139,431 | -35,379 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -9,214 | 15,110 | -95,838 | 35,848 | 5,643 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -6,694 | 7,465 | -73,521 | -69,321 | -79,782 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -80,926 | -213,980 | -92,872 | -159,920 | -94,201 |
Capital Expenditures | -14,048 | -14,336 | -5,992 | -5,961 | -3,249 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -25,417 | -304,394 | 264,963 | -89,753 | 228,522 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -39,465 | -318,730 | 258,971 | -95,714 | 225,273 |
Financing Cash Flow Items | — | — | 181 | -1,360 | 12,198 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 97,241 | 540,902 | -4,646 | 134,914 | 6,623 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -23,151 | 8,192 | 166,589 | -121,863 | 135,640 |